In recent news, EndWave (NASDAQ: ENWV) is to be acquired by G I G optics (OTCBB: GGOX) in a shared conversion agreement. Under the terms of this new merger agreement all outstanding shares of Endwave stock, including those issuable upon settlement of the outstanding restricted stock units and in the money options, will be converted into shares of GIG optics common stock such that immediately after the merger those shares represent 42.5% of all the other outstanding stocks.
So far shares have gained 2.68% with an increased volume of 88,885 traded shares, which is twice the volume of its average of 41,067 shares. To my surprise, price per share did not gain as much as it was expected from the announcement; however there is increased volatility as well as a surging volume. EndWave Corporation has been trading between two dollars and $3.61 for the last 52 weeks.
Endwave Corporation designs, manufactures, and markets radio frequency (RF) products that enable the transmission, reception and processing of high frequency RF signals. The Company's products consist of two product lines: transceiver modules and semiconductor product line. The Company's transceiver modules serve as the RF sub-system in digital microwave radios.
ZBB Energy (AMEX: ZBB) announced today the New York Stock Exchange Amex has allowed and accepted its compliance plan for continued listing. The stock has been in an uptrend from December 20, 2010 when the fresh crossover of the 20 day moving average and the 50 day moving average have catapulted the stock to new highs which broke the one dollar resistance at January 13, 2011. So far the stock has dipped below one dollar which triggered AMEX to consider delisting the stock from its exchange, but today the stock has showed considerable strength in maintaining its price per share of $1.13 with a moderate volume.
ZBB Energy Corporation, incorporated in 1998, designs, develops, manufactures and markets distributed intelligent power management platforms, which integrate all types of renewable and conventional power sources with storage technology.
Response Genetics, Inc. (NASDAQ: RGDX) has lost 1.3% or three cents at market open to settle at $2.27. The stock was in play today as the company announced the addition of Christine Meda as the company's president. In addition Kathleen Dannenberg who held this position prior to her, will continue to act as the CEO. Most recently Meda was president and CEO of our Arcxis Biotechnologies. The stock is trading at a very low volume so I would use caution if trying to trade the stock as low liquidity typically means a possibility that you might not get the price that you want when you're trying to sell the stock.
Response Genetics, Inc. focuses on providing molecular profiling services of tumor tissue that has been formalin-fixed and embedded in paraffin wax. The Company focuses on the commercialization of the ResponseDX tests.
Orient Paper (AMEX: ONP) announced that the currently operating medium production line and two offset printing paper production lines aggregate annual production capacity of these three lines to be projected at 300,000 tons. In recent filing the company announced that their total production capacity was 200,000 tons. Company subsequently demolished a 34,000 ton per annum production line in June 2000 and expects that the new medium production line and related facilities are still in the converter construction. The appraisal firm indicated that the estimated annual production capacity of 360,000 tons is reasonable for now.
Shares have gained 4.3% or $.22 to settle at $5.32 per share. Its volume has been light which is half the size of the regular volume traded of 601,925 shares. The company's market cap is $97.56 million with the P/E ratio of 6.55 for the past 12 months.
Orient Paper, Inc. is the holding company for Hebei Baoding Orient Paper Milling Company Limited (HBOP), a producer and distributor of paper products in China. HBOP is engaged mainly in production and distribution of products, such as corrugating medium paper, offset printing paper, writing paper and other paper and packaging related products. HBOP's main products include various specifications of corrugating medium paper, medium-grade offset printing paper, high-grade offset printing paper and writing paper.
Intellipharmaceutics International (NASDAQ: IPCI) has retained the services of Doll Consulting to assist the company with the commercialization of products and its controlled release generic drug portfolio and it's 505 new drug application portfolio. the stock has remained sluggish losing .5% or two cents to settle at $4.00 price per share. Its price per share has been ranging between $1.45 and $6.12 in the past 52 weeks with an average volume of 50,000 shares traded on daily basis.
Intellipharmaceutics International Inc. is a pharmaceutical
development company specializing in the controlled and targeted once-a-day
delivery of oral, solid dose pharmaceutical products. The Company's Hypermatrix
technology is a controlled-release drug delivery platform that can be applied
to the development of a range of existing and new pharmaceuticals.
OTCPicks.com is not a registered investment advisers or broker/dealer. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk. Always do you own homework before investing in any stock.
Forward-Looking Statement: This press release includes "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions.
Disclosure: OTCpicks.com has not been compensated for any stocks listed in this stock news report
